Multiple, but not isolated, yellow fever virus-associated orthoflavivirus immune histories drive antibody-dependent enhancement of Zika and dengue viruses
Gallon, S.; Baffour Tonto, P.; Ding, Y.; Chen, G.-H.; Naito-Keoho, K.; Brites, C.; Netto, E. M.; Wang, W.-K.; Herrera, B. B.
Show abstract
Antibody-dependent enhancement (ADE) is a major concern across orthoflavivirus infections, yet how multiple viral exposures shape enhancement risk remains incompletely understood. Here, we integrated serosurveillance from Saude, Brazil with functional immunologic analyses to define how yellow fever virus (YFV)-associated orthoflavivirus immune histories influence ADE phenotypes. Using serocomplex-specific anti-premembrane antibody profiling validated by microneutralization assays, plasma samples were stratified into YFV-only, YFV+DENV, and YFV+DENV+ZIKV exposure groups. In Fc gamma receptor-bearing U937 cells, YFV-only plasma demonstrated minimal enhancement activity, whereas cumulative orthoflavivirus exposure generated broader ADE phenotypes across heterologous viruses. In IFNAR1-/- passive-transfer models, YFV-only plasma did not enhance ZIKV or DENV2 infection in vivo. In contrast, YFV+DENV plasma increased ZIKV viremia and accelerated mortality kinetics, while YFV+DENV+ZIKV plasma demonstrated concentration-dependent enhancement phenotypes. Collectively, these findings indicate that isolated YFV immunity does not predispose to ADE, whereas cumulative orthoflavivirus exposure generates antibody repertoires capable of producing concentration-dependent enhancement in vivo.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses 96%
- Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses 95%
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination 94%
Similar papers in this journal
- Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses 97%
- Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques 95%
- Distinct pathway for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses 95%
Similar papers in this journal
- Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38 96%
- Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans 96%
- Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants 96%
Similar papers in this journal
- Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153 96%
- Functional, Immunogenetic, and Structural Convergence in Influenza Immunity between Humans and Macaques 95%
- Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.